(Adds investor quote)
By Stanley White
TOKYO, July 21 (Reuters) - Japanese stocks rose on Tuesday as signs of progress in developing a COVID-19 vaccine boosted investor confidence about a recovery in the global economy.
The Nikkei index ended up 0.73% at 22,884.22, with the healthcare and technology sectors leading the advance.
Initial findings from trials of three potential COVID-19 vaccines have shown encouraging results, raising hopes for a medical solution to a global pandemic that has triggered a sharp recession and caused more than half a million deaths. is certainly a positive development for stocks, but the upside is limited because we still don't know how long it will take for a vaccine to be completed or how it will be distributed," said Kiyoshi Ishigane, chief fund manager at Mitsubishi UFJ Kokusai Asset Management Co.
"At this point, it's better to buy on dips instead of aggressively chasing the upside."
There were 72 advancers on the Nikkei index against 148 decliners.
The largest percentage gainers in the index were pharmaceutical firm Daiichi Sankyo Co Ltd 4568.T , up 5.63%, followed by Z Internet services firm Holdings Corp 4689.T , gaining 5.39%, and silicon wafer maker Sumco Corp 3436.T , up by 4.24%.
Shares of mobile phone network operators NTT Docomo Inc 9437.T , KDDI Corp 9433.T , and Softbank Corp 9434.T dropped following a report that the Japanese government was considering preventing wireless carriers from charging customers fees when they switch providers.
The broader Topix .TOPX rose 0.36% to 1,582.74.
The volume of shares traded on the Tokyo Stock Exchange's main board .TOPX was 1.15 billion, compared with the average of 1.25 billion in the past 30 days. (Editing by Sherry Jacob-Phillips and Subhranshu Sahu)
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.